Integrating nitrosamine theoretical formation into Translational Pharmaceutics: Mitigating risks during accelerated formulation development in early phase clinical studies.
Saved in:
| Title: | Integrating nitrosamine theoretical formation into Translational Pharmaceutics: Mitigating risks during accelerated formulation development in early phase clinical studies. |
|---|---|
| Authors: | Cobice D; Quotient Sciences Ltd, Mere Way, Ruddington Fields, Nottingham, NG11 6JS, UK. Electronic address: diego.cobice@quotientsciences.com., Mamidala V; Quotient Sciences (US), 3080 McCann Farm Drive Garnet Valley, PA 19060, USA., Quick R; Quotient Sciences Ltd, Mere Way, Ruddington Fields, Nottingham, NG11 6JS, UK., Iyoha K; Quotient Sciences Ltd, Mere Way, Ruddington Fields, Nottingham, NG11 6JS, UK., Grayson-Gaunt D; Quotient Sciences Ltd, Mere Way, Ruddington Fields, Nottingham, NG11 6JS, UK., Rowe B; Quotient Sciences (US), 3080 McCann Farm Drive Garnet Valley, PA 19060, USA., Brooks J; Quotient Sciences (US), 3080 McCann Farm Drive Garnet Valley, PA 19060, USA., Giuliano G; Arcinova, UK Taylor Drive, Alnwick Northumberland, NE66 2DH, UK. |
| Source: | Journal of pharmaceutical sciences [J Pharm Sci] 2026 Jul 24, pp. 104434. Date of Electronic Publication: 2026 Jul 24. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 2985195R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-6017 (Electronic) Linking ISSN: 00223549 NLM ISO Abbreviation: J Pharm Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
